ENTO
Entero Therapeutics
ENTO
ENTO
12 hedge funds and large institutions have $1.05M invested in Entero Therapeutics in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
35% less capital invested
Capital invested by funds: $1.6M → $1.05M (-$554K)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$118K | |
| 2 | +$82K | |
| 3 | +$38.7K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$20K |
Top Sellers
| 1 | -$28K | |
| 2 | -$17K | |
| 3 | -$16K | |
| 4 |
US Bancorp
Minneapolis,
Minnesota
|
-$14K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7K |